DEFINITIVE PROXY STATEMENT

Company

Pasithea Therapeutics Corp.

Filed

July 24, 2025

Period of Report

September 3, 2025

Accession Number

0001213900-25-067344

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →